Celf1 knockdown remarkably improved the expressions of myogenic markers (MyoD, MyoG, Mef2C) in DM1, though the improvement levels were relatively lower than miR-322/-503 overexpression (Figs. 3B and 4I). The gene discussed is MYOD1; the disease is myotonic dystrophy type 1.